Document is current
Any future updates will be listed below
-
Authors
Kennedy, Lucy Boyce
Van Swearingen, Amanda E. D.
Lee, Marissa R.
Rogers, Layne W.
Sibley, Alexander B.
Sheng, Jeff
Zhang, Dadong
Qin, Xiaodi
Lipp, Eric S.
Kumar, Swaminathan
Joon, Aron
Shi, Pixu
Davies, Michael A.
Owzar, Kouros
Anders, Carey K.
Salama, April K.S.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30-CA014236-47, P50 CA221703-02)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
AIM at Melanoma
American Cancer Society
Melanoma Research Alliance
Cancer Fighters of Houston
Anne and John Mendelsohn Chair for Cancer Research
Melanoma Moon Shots Program of MD Anderson
Translating Duke Health
- License Information
-
More Information
Article History
Received: 29 October 2024
Accepted: 10 May 2025
First Online: 2 June 2025
Declarations
:
: Collection of tissue samples and clinical information was approved by the Duke University Institutional Review Board (Pro00103267).
: Not applicable.
: Not applicable.
: LBK is PI of research grants paid to Cleveland Clinic by EpicentRx, Ideaya, and Regeneron. MAD has been a consultant to Replimmune, Roche/Genentech, Array, Pfizer, Novartis, BMS, GSK, Sanofi-Aventis, Vaccinex, Apexigen, Eisai, Iovance, Merck, and ABM Therapeutics, and he has been the PI of research grants to MD Anderson by Roche/Genentech, GSK, Sanofi-Aventis, Merck, Myriad, Oncothyreon, Pfizer, ABM Therapeutics, and LEAD Pharma. AKSS has been a consultant to Bristol Myers Squibb, Novartis, Pfizer, Iovance and Regneron. AKSS is PI of research grants (paid to institution) from Ascentage, BMS, Ideaya, Immunocore, Merck, Olatec Therapeutics, Regeneron, Replimune, and Seagen. CKA has received research funding from PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer, Astra Zeneca, Elucida, Caris, Incyclix, Beigene. CKA has been a compensated consultant for Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex, Roche, and has received royalties from UpToDate and Jones and Bartlett. The other authors have no conflicts to disclose.
